Trade Pfizer ^PFE

Pfizer (NYSE:PFE) Shares Up 1.8% - Still a Buy?

Investors Purchase Large Volume of Call Options on Pfizer (NYSE:PFE)

Jefferies says market nears short term “peak RFK negativity", Vaccine makers up By Investing.com

Thompson Siegel & Walmsley LLC Cuts Stake in Pfizer Inc. (NYSE:PFE)

Jefferies holds Moderna at $50 target, cites RFK concerns By Investing.com

Batya Swift Yasgur, MA, LSW | MDedge

FDA Accepts Bayer's Application for Label Expansion of Nubeqa - November 22, 2024 - Zacks.com

Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug - November 22, 2024 - Zacks.com

Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View - November 22, 2024 - Zacks.com

Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics - November 22, 2024 - Zacks.com

Axial Spondyloarthritis Therapeutics Market Size was ~USD 9 Million in 2023, estimated DelveInsight

Pfizer (NYSE:PFE) Trading Down 0.2% - Should You Sell?

Ontario Teachers Pension Plan Board Sells 63,563 Shares of Pfizer Inc. (NYSE:PFE)

Smithfield Trust Co Increases Holdings in Pfizer Inc. (NYSE:PFE)

Blackhawk Capital Partners LLC. Sells 1,685 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Purchased by Charles Schwab Investment Management Inc.

Mizuho Securities USA LLC Sells 69,459 Shares of Pfizer Inc. (NYSE:PFE)

Darwin Wealth Management LLC Invests $90,000 in Pfizer Inc. (NYSE:PFE)

Massachusetts Financial Services Co. MA Trims Stake in Pfizer Inc. (NYSE:PFE)

Integrated Investment Consultants LLC Raises Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Acquired by America First Investment Advisors LLC

Pfizer Inc. (NYSE:PFE) Shares Sold by Intech Investment Management LLC

Brokers Issue Forecasts for Pfizer's Q4 Earnings (NYSE:PFE)

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) | Morningstar

Viatris fined in Morocco over merger notification, sources say By Reuters

Personalised antimicrobial susceptibility testing with clinical prediction modelling informs appropriate antibiotic use

MediaPost Publications - Marketing Daily 11/21/2024

Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU - November 21, 2024 - Zacks.com

The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair - November 21, 2024 - Zacks.com

5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return - November 21, 2024 - Zacks.com

Fall Vaccine Updates From the Advisory Committee on Immunization Practices: New Recommendations | MDedge

BlinkLab to Participate in the Landmark Monash University Autism/ADHD MAGNET Project

Meta, Pfizer on DOL List of Upcoming Contractor Anti-Bias Audits

Pfizer (NYSE:PFE) Stock Price Down 0.6% - Should You Sell?

Pzena Investment Management LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief

Pfizer Inc. (NYSE:PFE) Shares Sold by Moors & Cabot Inc.

News Highlights: Top Company News of the Day - Wednesday at 9 AM ET | Morningstar

First Horizon Advisors Inc. Purchases 95,749 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Names Chris Boshoff Chief Scientific Officer And President, R&D, Effective Jan.1

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies | Morningstar

Advisors Asset Management Inc. Acquires 28,704 Shares of Pfizer Inc. (NYSE:PFE)

News Highlights: Top Company News of the Day - Wednesday at 7 AM ET | Morningstar

Commerce Bank Has $60.56 Million Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Names Oncology Head Boshoff as Chief Science Officer

Pfizer Gets European Approval of Hympavzi Hemophilia Drug | Morningstar

Pfizer names Chris Boshoff as new R&D chief starting 2025 By Investing.com

Pfizer Inc. (NYSE:PFE) Shares Bought by Pathstone Holdings LLC

Pfizer Inc. (NYSE:PFE) Stake Raised by Thrivent Financial for Lutherans

Pfizer's HYMPAVZI Approved In EU For Treatment Of Severe Hemophilia A Or B Without Inhibitors

StockNews.com Downgrades Pfizer (NYSE:PFE) to Buy

Pfizer names insider Chris Boshoff as R&D chief By Reuters

Pfizer Appoints Chris Boshoff as Chief Scientific Officer and President of R&D By Investing.com

Pfizer Announces EU Approval of HYMPAVZI for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors By Investing.com

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - November 20, 2024 - Zacks.com

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan - November 20, 2024 - Zacks.com

5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential - November 20, 2024 - Zacks.com

Pfizer names oncology chief Chris Boshoff as new chief scientific officer | Morningstar

Healthcare Players React To Dr. Oz Joining RFK Jr In Trump Lineup 11/21/2024

Pfizer (NYSE:PFE) Trading Up 0.7% - Here's What Happened

Pfizer Inc. (NYSE:PFE) Shares Acquired by Meeder Advisory Services Inc.

High-Flying Genetics Testing Firm GeneDx Hires Ex-Zoetis GC as Legal Chief

Pfizer Inc. (NYSE:PFE) Holdings Lowered by PNC Financial Services Group Inc.

Pfizer Inc. (NYSE:PFE) Holdings Lowered by Banque Cantonale Vaudoise

Verity & Verity LLC Purchases 108,863 Shares of Pfizer Inc. (NYSE:PFE)

OneAscent Financial Services LLC Invests $739,000 in Pfizer Inc. (NYSE:PFE)

Belmont Capital LLC Has $270,000 Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Holdings Decreased by AMG National Trust Bank

These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth - November 19, 2024 - Zacks.com

The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and Qualcomm - November 19, 2024 - Zacks.com

Antifungal Drugs Market Growth Driven by Rising Fungal Infections Worldwide – Express Press Release Distribution

Global Narcolepsy Treatment Market Set to Reach USD 6.67 Billion by 2028 at a 5.7% of CAGR, Driven by Advancements in Care and Growing Awareness – Express Press Release Distribution

Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’

Pfizer (NYSE:PFE) Stock Price Up 0.6% - Here's What Happened

Jim Cramer Talked About These 11 Stocks Recently

Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now?

TrinityPoint Wealth LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)

Vaughan Nelson Investment Management L.P. Has $2.57 Million Position in Pfizer Inc. (NYSE:PFE)

Buy 5 U.S. Bigwigs on the Dip for Sparkling Returns in the Short Term - November 18, 2024 - Zacks.com

FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria - November 18, 2024 - Zacks.com

Pfizer (NYSE:PFE) Trading Down 3.8% - Here's Why

Asian Market Update: Hang Seng Index Falls on Baidu Slumps

Stock Market Today: Dow and S&P 500 Post Gains Ahead of Nvidia Earnings

Super Micro Stock Surges on Decision to Maintain Nasdaq Listing

Silver Thursday & the Hunt Brothers: History Repeating?

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Nasdaq futures decline, Nvidia shares dip following the earnings report

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024